Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ACADIA Pharmaceuticals Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ACAD
Nasdaq
2836
www.acadia.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ACADIA Pharmaceuticals Inc.
Can Acadia (ACAD) Run Higher on Rising Earnings Estimates?
- Aug 6th, 2026 10:20 am
The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight
- Aug 6th, 2026 8:31 am
3 Medical Stocks Standing Out After Crushing Q2 Earnings Expectations
- Aug 5th, 2026 5:10 pm
ACAD Q2 Earnings and Revenues Beat, '26 View Raised on Product Sales
- Aug 5th, 2026 9:44 am
ACADIA Pharmaceuticals Inc (ACAD) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and ...
- Aug 4th, 2026 11:06 pm
ACADIA Pharmaceuticals Q2 Earnings Call Highlights
- Aug 4th, 2026 4:03 pm
Acadia Pharmaceuticals (ACAD) Q2 Earnings and Revenues Beat Estimates
- Aug 4th, 2026 3:40 pm
Acadia Pharmaceuticals Reports Second Quarter 2026 Financial Results
- Aug 4th, 2026 2:05 pm
Viatris Gears Up to Report Q2 Earnings: What's in the Cards?
- Aug 4th, 2026 9:37 am
Outlook Therapeutics to Report Q3 Earnings: What's in the Cards?
- Aug 3rd, 2026 8:58 am
Dementia-related Psychosis Market Gearing Up for Outstanding Expansion at a CAGR of 26.2% During the Forecast Period (2026-2036) | DelveInsight
- Aug 3rd, 2026 8:31 am
Acadia Pharmaceuticals to Participate in the Canaccord Genuity 46th Annual Growth Conference
- Jul 30th, 2026 3:57 pm
HRMY or ACAD: Which Is the Better Value Stock Right Now?
- Jul 30th, 2026 9:40 am
ACADIA Pharmaceuticals (ACAD) Stock Still Looks Below Fair Value Despite Clinical Risk
- Jul 30th, 2026 6:09 am
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Jul 29th, 2026 8:00 am
Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?
- Jul 28th, 2026 8:00 am
The Zacks Analyst Blog Highlights CVS Health, Cardinal Health, Humana and ACADIA Pharmaceuticals
- Jul 28th, 2026 3:02 am
The Zacks Analyst Blog Highlights Harmony Biosciences, Acadia Pharmaceuticals, Biogen, Insmed and Agios Pharmaceuticals
- Jul 28th, 2026 2:58 am
Watch These 5 Biotech Stocks for Q2 Earnings: Beat or Miss?
- Jul 27th, 2026 10:36 am
4 Medical Stocks With the Right Setup for Q2 Earnings Beats
- Jul 27th, 2026 10:03 am
Scroll